Delivery Order 36F79723D0136-36C26024F0268
Award Date 4/1/24
Potential Completion Date 6/30/24
Potential Value Not listed
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
East Cambridge, MA 02141, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amylyx Pharmaceuticals Inc. was awarded a $46,799.80 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide its amyotrophic lateral sclerosis drug RELYVRIO. The order, issued without a set-aside designation, has a period of performance through May 1, 2024 for delivery to a location in Cambridge, Massachusetts. Amylyx holds several federal vehicles that facilitate provision of its pharmaceutical...
- Amylyx Pharmaceuticals Inc. was awarded a $56,159.76 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to provide its amyotrophic lateral sclerosis drug RELYVRIO. The delivery order, which does not have a set-aside designation, has a completion date of May 28, 2024 and was awarded on February 27, 2024. Amylyx has previously received multiple prime contract awards totaling over $3 million from August 2023...
- Amylyx Pharmaceuticals Inc., doing business as Amylyx, has been awarded a $10,583.64 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to provide RELYVRIO. The prime contractor Amylyx will deliver the products from its place of performance in Cambridge, Massachusetts between July 27, 2023 and September 27, 2023. No major subcontractors or set aside designations were indicated. This delivery...
- Amylyx Pharmaceuticals Inc., doing business as Amylyx, has been awarded a $74,879.68 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to provide RELYVRIO. The prime contractor Amylyx will deliver the products from its place of performance in Cambridge, Massachusetts between August 10, 2023 and September 30, 2023 to support the VA VHA VISN 21's healthcare programs for veterans. No major...
- Amylyx Pharmaceuticals Inc., doing business as Amylyx, has been awarded a $74,879.68 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to provide RELYVIO. The contract has a period of performance from July 13, 2023 through September 13, 2023 and will be performed in Cambridge, Massachusetts. VHA VISN 21 oversees healthcare services for veterans in northern New England. This delivery order...
- This federal contract award is for RELYVRIO, a pharmaceutical product developed by Amylyx Pharmaceuticals Inc. (Amylyx) for the treatment of amyotrophic lateral sclerosis (ALS). The contract, awarded by the U.S. Department of Veterans Affairs (VA), is a firm-fixed-price delivery order with a ceiling value of $110,015.32 and a period of performance through March 31, 2024. Amylyx, a self-certified small disadvantaged business, has secured multiple contract vehicles with the VA, including a Federal...
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., doing business as Amylyx, a self-certified small disadvantaged business. The contract, valued at $355,678.72, is for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), to the Puget Sound VA Medical Center. The contract has an ultimate completion date of March 31, 2023. Amylyx holds several significant Indefinite Delivery...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Amylyx Pharmaceuticals Inc., a self-certified small disadvantaged business, for the provision of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS). The contract, valued at $44,459.84, was awarded on January 6, 2023, with a completion date of January 31, 2023. Amylyx holds several significant Indefinite Delivery Vehicles (IDVs) with the VA, including a Federal Supply...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $93,599.60 firm fixed price delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The contract is for the delivery of RELYVRIO SODIUM PHENYLBUTYRATE to support VHA programs. Amylyx will provide the pharmaceutical product to multiple VA medical centers in the region from November 2023 through January 2024. No subcontractors...
- This federal contract award to Amylyx Pharmaceuticals Inc., doing business as Amylyx, is for the delivery of RELYVRIO Sodium, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS). The $42,334.56 firm-fixed-price delivery order was issued by the Veterans Integrated Service Network 21 (VISN 21), a division of the Department of Veterans Affairs (VA). The contract has no set-aside designation and is intended to supply RELYVRIO to VA medical facilities in the western United States....